Defects in sialylation are known to have serious consequences on podocyte function leading to collapse of the glomerular filtration barrier and the development of proteinuria. However, the cellular processes underlying aberrant sialylation in renal disease are inadequately defined. We have shown in cultured human podocytes that puromycin aminonucleoside (PAN) downregulates enzymes involved in sialic acid metabolism and redox homeostasis and these can be rescued by cotreatment with free sialic acid. The aim of the current study was to ascertain whether sialic acid supplementation could improve renal function and attenuate desialylation in an in vivo model of proteinuria (PAN nephrosis) and to delineate the possible mechanisms involved. PAN nephrotic rats were supplemented with free sialic acid, its precursor N-acetyl mannosamine or the NADPH oxidase inhibitor apocynin. Glomeruli, urine, and sera were examined for evidence of kidney injury and therapeutic efficacy. Of the three treatment regimens, sialic acid had the broadest efficacy in attenuating PANinduced injury. Proteinuria and urinary nephrin loss were reduced. Transmission electron microscopy revealed that podocyte ultrastructure, exhibited less severe foot process effacement. PAN-induced oxidative stress was ameliorated as evidenced by a reduction in glomerular NOX4 expression and a downregulation of urine xanthine oxidase levels. Sialylation dysfunction was improved as indicated by reduced urinary concentrations of free sialic acid, restored electrophoretic mobility of podocalyxin, and improved expression of a sialyltransferase. These data indicate that PAN induces alterations in the expression of enzymes involved in redox control and sialoglycoprotein metabolism, which can be ameliorated by sialic acid supplementation possibly via its properties as both an antioxidant and a substrate for sialylation.
Defects in sialylation are known to have serious consequences on podocyte function leading to collapse of the glomerular filtration barrier and the development of proteinuria. However, the cellular processes underlying aberrant sialylation in renal disease are inadequately defined. We have shown in cultured human podocytes that puromycin aminonucleoside (PAN) downregulates enzymes involved in sialic acid metabolism and redox homeostasis and these can be rescued by cotreatment with free sialic acid. The aim of the current study was to ascertain whether sialic acid supplementation could improve renal function and attenuate desialylation in an in vivo model of proteinuria (PAN nephrosis) and to delineate the possible mechanisms involved. PAN nephrotic rats were supplemented with free sialic acid, its precursor N-acetyl mannosamine or the NADPH oxidase inhibitor apocynin. Glomeruli, urine, and sera were examined for evidence of kidney injury and therapeutic efficacy. Of the three treatment regimens, sialic acid had the broadest efficacy in attenuating PANinduced injury. Proteinuria and urinary nephrin loss were reduced. Transmission electron microscopy revealed that podocyte ultrastructure, exhibited less severe foot process effacement. PAN-induced oxidative stress was ameliorated as evidenced by a reduction in glomerular NOX4 expression and a downregulation of urine xanthine oxidase levels. Sialylation dysfunction was improved as indicated by reduced urinary concentrations of free sialic acid, restored electrophoretic mobility of podocalyxin, and improved expression of a sialyltransferase. These data indicate that PAN induces alterations in the expression of enzymes involved in redox control and sialoglycoprotein metabolism, which can be ameliorated by sialic acid supplementation possibly via its properties as both an antioxidant and a substrate for sialylation. Efficient functioning of the glomerular permselective barrier is thought to rely on the integrity of the anionic glycocalyx associated with the glomerular filter. Evidence suggests that the charge characteristics of this 'polyanion', are important for efficient plasma ultrafiltration. 1 In its absence, normal foot process structure and filtration slit organization become distorted leading to the collapse of the filtration barrier [2] [3] [4] [5] and leakage of proteins into the urine. A number of studies have demonstrated that the negatively charged sugar sialic acid is important for this function as its removal by infusion of sialidase or neutralisation of surface negative charge by polycations have resulted in podocyte effacement and proteinuria. 6, 7 Conversely, infusion of α1-acid glycoprotein, a sialylated acute phase protein, into experimental animals with puromycin aminonucleoside (PAN) nephrosis, improved podocyte ultrastructure. 8 In some human proteinuric renal diseases, reduced glomerular sialylation is also accompanied by reduced sialic acid content at other sites, including red blood cells, suggesting a more widespread defect of sialylation. 9 Despite the fact that alterations in the sialic acid content of the glomerular permselective barrier of PAN nephrotic rats have been recognized since the 1970s and 80s, 10-13 the mechanisms underlying these observations still remain incompletely understood. The proteinuria associated with this model is thought to be initiated by reactive oxygen species (ROS) 14 and antioxidant treatments have been shown to provide protection against PAN-induced alterations in podocyte foot process morphology. 15 Possibly related to this is the fact that, in addition to its negative charge, sialic acid also has a unique α-ketocarboxylic acid structure, which has been shown to chemically scavenge H 2 O 2 . 16 Consequently loss of sialic acid not only results in depletion of negative charge but also a source of local, inherent ROS scavenging activity.
We have recently shown that sialic acid was able to quench the oxidative burst of superoxide anions induced by PAN in cultured human podocytes. In addition, PAN induced the downregulation of sialyltransferases, an effect which was at least partially restored by sialic acid treatment. This effect was also mimicked by addition of exogenous superoxide dismutase. 13 These data, therefore, suggest that there could be a link between aberrant sialylation and oxidative stress.
Dietary supplementation of the sialic acid precursor N-acetyl mannosamine (ManNAc) has previously been shown to correct defective sialylation and improve the accompanying renal lesions in murine models of hereditary inclusion body myopathy. 17, 18 We hypothesize that dietary supplementation of PAN nephrotic rats with free sialic acid, given its antioxidant properties, may be a more effective treatment modality in a proteinuric model of kidney disease exhibiting both desialylation and oxidative stress.
MATERIALS AND METHODS
In Vivo Study PAN nephrosis was induced in 200 g male Sprague Dawley rats (Charles River) by i.p. injection of 10 mg PAN (Sigma)/ 100 g body weight (day 1). Control rats received saline (vehicle). All rats were fed a standard chow and were given free access to drinking water, which was either tap water (A), or tap water supplemented with 1 mg/ml sialic acid (Carbosynth) (B), 1 mg/ml ManNAc (Carbosynth; C) or 2 mg/ml apocynin (Sigma; D). Each PAN-treated group contained eight rats (four rats per group for saline controls). Overnight urines (18 h) were collected on day 9 (peak proteinuria) by housing rats in metabolic cages. Prior to sacrifice by cervical dislocation aortic blood samples were taken under anesthesia. Kidneys were removed and processed for analysis. All animals were housed in standard conditions. All experimental procedures were conducted in accordance with the UK Animals (Scientific procedures) Act. Two PANtreated rats receiving tap water only were excluded as one died and one failed to respond to PAN.
Glomerular Preparations
Glomeruli were prepared by standard serial sieving of kidney cortex as previously described. 19 Glomeruli were washed in Hank's balanced salt solution and resuspended in lysis buffer (0.01 M β-glycerophosphate, 1 mM EDTA, 1 mM EGTA, 0.05 M Tris-HCl, 1 mM sodium orthovanadate, 1 mM benzamidine, 0.2 mM PMSF, 1 μg/ml pepstatin A, 1 μg/ml leupeptin, 0.1% β-mercaptoethanol, 1% Triton-X 100, 50 mM sodium fluoride).
Urine Analysis
Whole urines were analyzed for urea, creatinine, and sialic acid concentrations. Urine sediments were analyzed by western blotting. Urines were corrected for excreted volume then 500 μl aliquots were centrifuged for 30 min at 13 000 r.p.m. at 4°C. The resulting pellets were resuspended in 80 μl PBS.
Urine Xanthine Oxidase activity 1.5 ml aliquots of urine were centrifuged at 13 000 r.p.m. for 2 min. The resulting sediments were resuspended in 100 μl xanthine oxidase assay activity buffer and sonicated with two 5 s bursts. Insoluble material was removed by centrifugation at 13 000 r.p.m. for 2 min. Aliquots of cleared supernatant (50 μl) were analyzed using a Xanthine Oxidase Activity Assay Kit (Sigma) as directed in the manufacturer's protocol.
Renal Function
Proteinuria was assessed by measuring protein concentrations in whole urine using BioRad DC assay. Urea and creatinine concentrations in urine and serum were determined by QuantiChrome assays according to manufacturer's protocols.
SDS-PAGE and Western Blotting
Urine pellet lysates (sediments) or glomerular lysates (30 μg) were mixed with an equal volume of reducing sample buffer, heated to 100°C for 5 min, and resolved by SDS-PAGE on gels of appropriate pore size. Resolved proteins were electrophoretically transferred to nitrocellulose membranes. The membranes were blocked with 5% (w/v) skimmed milk in Tris-buffered saline containing 0.05% Tween 20 (TTBS), and then incubated overnight at 4°C with primary antibody. The membranes were washed with TTBS after which bound primary antibody was detected by incubation with the appropriate horseradish peroxidase-conjugated secondary antibody at room temperature for at least 2 h. Immunoreactive proteins were detected by enhanced chemiluminescence (Super Signal West Pico, Pierce). Protein loading was normalized by reprobing the membranes with antibodies against α-tubulin. Band intensities were quantified using a BioRad GS-700 imaging densitometer.
Antibodies: mouse anti-desmin, rabbit anti-podocalyxin, mouse anti-nephrin, rabbit anti-NOX4, rabbit anti-xanthine oxidase and rabbit anti-beta-galactoside alpha-2,3-sialyltransferase 3 (ST3Gal 3), anti-neuraminidase (neu)-3 (Santa Cruz Biotechnologies), biotinylated sambus nigra agglutinin (SNA), and biotinylated maakia amurensis (MALII; Vector laboratories), rabbit anti-beta-galactoside alpha-2,6-sialyltransferase 1 (ST6Gal 1), rabbit anti-uridine diphospho-Nacetylglucosamine 2-epimerase/N acetyl mannosamine kinase (GNE; Biorbyt), rabbit anti-α-tubulin (Cell Signalling Technology).
Sialic Acid Levels
Free and total sialic acid concentrations in whole urine or serum were measured using Quantichrome sialic acid assays.
Electron Microscopy
For transmission electron microscopy, small pieces of rat kidney cortex were fixed overnight in 2% gluteraldehyde/4% formaldehyde in 0.1 M cacodylate buffer with 2 mM calcium chloride (pH = 4) and then washed in the same cacodylate /CaCl buffer. The tissue fragments were then fixed with 1% OsO4/1.5% potassium ferricyanide for 2 h, washed with distilled, de-iodized water and finally tertiary fixed with 1% uranyl acetate for 1 h. The tissue was then serially dehydrated through ethanol and propylene oxide and embedded in Spurr's modified low-viscosity resin. Thin sections of~80 nm thickness were cut using a Reichert Ultracut S ultramicrotome, collected onto copper mesh grids, and stained with Reynolds' lead citrate. The grids were viewed under a JEOL JEM-1400 electron microscope at 80 kV. Digital images were recorded using a SIS digital camera and iTEM software. The electron micrographs were then analyzed by a renal pathologist blinded to the treatments.
Statistics
Data are presented as means ± s.e.m. Multiple comparisons between means were determined by an analysis of variance with Bonferroni correction. Statistical significance was defined as Po0.05.
RESULTS

Kidney Function
Dietary supplementation of PAN nephrotic rats demonstrated that sialic acid significantly reduced proteinuria by 31% (P = 0.03; Figure 1 ). However, no significant difference was observed between treatments.
All PAN-treated rats, regardless of supplementation, had raised serum creatinine concentrations (Po0.009; Figure 2a ). In contrast, there was no difference in urine creatinine concentrations between supplements with the exception of the apocynin-treated rats that exhibited higher levels (Po0.001; Figure 2b ).
All PAN-treated rats had raised serum urea levels compared with saline controls (P ≤ 0.001; Figure 2c ). In contrast, there was no significant difference in urine urea concentrations between supplements with the exception of ManNAc rats, which exhibited lower levels than those of saline controls (P = 0.009; Figure 2d ).
Podocyte Injury
Podocyte injury or loss was determined by analyzing urine sediments for the slit diaphragm protein nephrin. Western blotting demonstrated significantly reduced nephrin levels in the urines of sialic acid supplemented rats (P = 0.008; Figure 3 ).
Western blotting of glomerular lysates demonstrated that PAN treatment upregulated desmin, a marker of cytoskeletal damage often used as a marker of podocyte injury. 20 Sialic acid supplementation significantly attenuated this effect more efficiently than the other supplements (P = 0.03; Figure 4) .
Transmission electron microscopy indicated that all PANtreated animals exhibited some degree of foot process effacement compared with saline controls. However, supplementation with sialic acid or apocynin reduced the extent of the damage compared with PAN-treated animals on water alone or supplemented with ManNAc (Figure 5a and e).
Oxidative Stress
As oxidative stress is considered to be the initiating trigger for podocyte damage in PAN nephrosis, western blotting was used to examine the expression of enzymes involved in redox control. PAN significantly raised glomerular expression of the NOX4 subunit of NADPH oxidase compared with saline controls (Po0.003), while sialic acid significantly lowered PAN-induced expression (P = 0.007; Figure 6a) .
No difference in glomerular XO expression was observed between any of the rats regardless of treatment (data not shown). However, XO levels in urine were significantly elevated in PAN nephrotic rats compared with saline controls (Po0.001; Figure 6b ). Both sialic acid and apocynin supplementation significantly reduced urine levels (Po0.005 and Po0.001, respectively). Analysis of XO activity in urines revealed that PAN-treated rat urines exhibited significantly raised activity levels compared with saline controls (Po0.002; Figure 6c ). Urines from sialic acid and apocynin supplemented rats exhibited less XO activity than PAN-treated rats on water alone (Po0.02 and Po0.03, respectively).
Sialylation
Raised serum and urine sialic acid levels accompanied by tissue desialylation are usually a harbinger of an underlying problem with sialic acid metabolism. Analysis of urines and sera demonstrated that sialic acid and apocynin supplementation significantly reduced free sialic acid levels in the urines of PAN nephrotic rats (Po0.03 and Po0.04, respectively; Figure 7a ). None of the supplements reduced free or total sialic acid levels in serum (Figure 7c and d) .
To examine the effects of supplementation on the sialylation status of glomerular proteins, glomerular lysates were examined for the expression of sialoglycoproteins expressing sialic acid residues in α2-6 or α2-3 linkage using lectins SNA and MALII, respectively. Western blotting revealed two major sialylated bands with molecular weights Figure 3 Effect of supplementation on urine nephrin. Rat urines were diluted to correct for excreted volume. Equal volumes were then centrifuged to generate sediment pellets, which were analyzed by western blotting for the podocyte specific protein nephrin. Western blot shows reduced urine nephrin loss in PAN SA (*P = 0.008 vs PAN water ) and in PAN apo (**Po0.03 vs PAN water ). Representative blot is shown. Histogram shows densitometric data (n = 4). apo, apocynin; ManNAc, N-acetyl mannosamine; PAN, puromycin aminonucleoside; SA, sialic acid. 
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Western blotting of rat urine sediments with SNA demonstrated that sialic acid supplementation result in the excretion of fewer α2-6-sialylated glycoproteins than PAN rats on other supplements (Figure 8b ). MALII staining indicated that α2-3-sialylated glycoproteins were largely detected in the urines of those rats receiving tap water or ManNAc (Figure 8b ).
Podocalyxin is a highly sialylated podocyte protein known to have an important role in the maintenance of foot processes. 21, 22 Western blotting of glomerular lysates from 
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IZA Pawluczyk et al PAN-treated rats demonstrated retarded mobility of podocalyxin on SDS-PAGE-a phenomenon consistent with a change in charge and glycosylation. Sialic acid supplementation appeared to correct the apparent change in electrophoretic mobility (Figure 8c ). In order to determine the cause of the altered sialylation, the expression of a number of enzymes involved in sialic acid metabolism was investigated. Immunoblotting indicated that GNE, the rate limiting enzyme of the sialic acid biosynthetic pathway was significantly upregulated in PAN-treated rats compared with saline controls (Po0.03). Apocynin supplementation significantly reduced this upregulation (Po0.03; Figure 9 ).
Sialyltransferases catalyse the transfer of CMP-activated sialic acid residues onto glycoproteins in the Golgi apparatus. Western blotting demonstrated that PAN treatment significantly reduced the expression of sialyltransferase ST6Gal 1 and (Po0.02). Both sialic acid and apocynin supplementation at least partially restored expression levels (Figure 10a) . In contrast, expression of ST3Gal 3 was upregulated by PAN. However, only apocynin supplementation significantly restored levels closer to those of control (Figure 10b ).
Reduced sialic acid levels can also occur as a result of excision. Western blotting for neu-3, the sialidase that cleaves sialic acid from renal gangliosides showed no difference in expression between any of the treatments (data not shown).
DISCUSSION
The results of this study have demonstrated that sialic acid supplementation is able to ameliorate the effects of PANinduced injury by reducing glomerular damage and subsequent proteinuria more effectively than apocynin or ManNAc. However, it must be stressed that although proteinuria was reduced, sialic acid supplementation had no effect upon serum creatinine levels that remained raised. As well as reducing podocyte effacement, sialic acid supplementation altered the pattern of podocyte protein expression in the glomerular lysates and urines of PAN nephrotic rats. More importantly, sialic acid was able to restore the expression of some of the enzymes involved in sialic acid metabolism and redox homeostasis.
Raised serum and urine sialic acid levels are usually a harbinger of an underlying defect of sialic acid metabolism. [23] [24] [25] Although PAN-elevated serum sialic acid levels were not modified by dietary supplementation, urinary excretion of free sialic acid was significantly reduced, indicating some degree of sialylation restoration.
As aberrant sialylation can occur as a result of a dysfunction in any one of a number of pathways involved in the production sialoglycoconjugates, we examined the expression of some of the enzyme involved in this process. GNE is the ubiquitously expressed, rate limiting enzyme of sialic acid biosynthesis. We observed an upregulation of GNE expression that could imply an increased through-put of sialic acid, perhaps in an attempt to correct reduced sialylation. However, in contrast to the in vivo data, we observed reduced expression of GNE in response to PAN in cultured human podocytes, an effect that was not rescued by sialic acid Sialic acid therapy in PAN nephrosis IZA Pawluczyk et al supplementation. 13 It is now generally considered that cells have an excess of GNE beyond the amount required to supply flux into the sialic acid pathway, implying that GNE, as well as being involved in sialic acid biosynthesis, has other noncanonical functions. 26, 27 One might, therefore, surmise that the PAN-induced increase in GNE does not directly impact on its synthetic role but may modulate other non-canonical signaling pathways and genes involved in kidney injury. Studies in other organ systems have shown that desialylation often occurs as a result of altered expression of sialyltransferases. 28, 29 This study demonstrated that PAN modulated the glomerular expression of sialyltransferases. In this case, however, apocynin proved to be a better restorer of expression than sialic acid. Our previous in vitro investigations demonstrated that the PAN-induced reduction in expression of sialytransferases in cultured human podocytes was improved by sialic acid treatment, an effect which was also mimicked by treatment with the enzyme superoxide dismutase. 30 These data would suggest that the PAN-induced alterations in sialyltransferase expression are modulated by the oxidative milieu and could explain why sialic acid supplementation, by virtue of its antioxidant capacity, can restore some expression.
Reduced sialylation can also arise as a result of the actions of neuraminidases. We found that neu-3, a sialidase that cleaves sialic acid from gangliosides, was not significantly affected by PAN treatment (data not shown). These data concur with the observations of others who also failed to detect changes in sialidase activity in PAN nephrotic rats, despite the loss of glomerular sialic acid. 31 Eguchi et al 32 have proposed that desialylation can occur as a direct result of the actions of ROS with the terminal sialic acid residues of oligosaccharide side chains. They suggested that the superoxide anion and related ROS specifically attack the carboxyl group of the terminal sugar leading to the cleavage of the glycosidic link and liberating the sialic acid residue from cell surface oligosaccharides. 32 PAN nephrosis has long been thought to be initiated by oxidative podocyte damage 14, [33] [34] [35] and a number of studies have described the protective effects of antioxidants in this experimental model. 15, 36, 37 However, no studies have yet described the effects of free sialic acid on PAN-induced redox alterations. As puromycin is metabolized to xanthine by glomerular enzymes, we examined the xanthine oxidase pathway to ascertain whether it was involved in the initiation of oxidative podocyte damage. Although we found no evidence of altered glomerular XO expression, which was in accordance with the observations of Ginevri et al, 33 we did observe changes in enzyme protein and activity levels in the urine of PAN-treated rats. Although XO is generally thought to be an oxidative enzyme, what is much less appreciated is that uric acid, a product of XO activity, is also a potent ROS scavenger. 38 The antioxidant capacity in serum strongly correlates with urate levels. 38 Therefore, in the context of PAN nephrosis, loss of XO, seen as increased urine xanthine oxidase, could be consistent with an injurious, oxidative effect, as it potentially results in reduced levels of a potent serum antioxidant.
NADPH oxidase is generally considered to be a major source of non-phagocytic cell superoxide anion production. 39 Sialic acid supplementation downregulated the expression of the PAN-induced NOX4 subunit and appeared to do this more efficiently than apocynin. But this may be due to the fact that apocynin exerts its effects by inhibiting the assembly of enzymic subunits rather than by reducing expression.
Whether oxidative stress and desialylation are causally related in renal disease is yet to be unequivocally established, although the results presented here together with those of our previous in vitro study suggest this could be the case. Furthermore, oxidative stress-related desialylation has previously been reported in association with Dengue fever 40 and hyperthyroidism. 41 Of the three supplements, sialic acid proved to have the broadest spectrum of efficacy, although a number of the beneficial effects were also common to apocynin. Again this would imply that in those parameters, the effects of sialic acid were largely mediated via its properties as an antioxidant. Despite the efficacy of ManNAc in GNE myopathy, 17, 18 its benefits as a therapeutic supplement in this study were not comparable to those of sialic acid. In experimental murine GNE myopathy, desialylation occurs as a consequence of a specific mutation in one enzyme of the sialic acid biosynthetic pathway, which although lethal, is adequately bypassed using ManNAc as a substrate (and also notably sialic acid 42 ). However, the prevailing oxidative conditions encountered in PAN nephrosis clearly affect the expression of a number of enzymes, any of which could affect the phenotype of the disease. The efficacy of sialic acid supplementation under these conditions must therefore lie in its additional property as an antioxidant.
It would have been illuminating to carry out activity assays on all of the enzymes of sialic acid metabolism and redox control investigated in this study in addition to measuring expression levels. However, the amount of glomerular tissue generated did not allow for this and therefore this remains a drawback of the study.
In conclusion, this study has illustrated that a number of enzymes involved in sialic acid metabolism and redox control are affected by PAN treatment, the expression of some can be rescued by sialic acid supplementation. This study provides evidence to support further investigation of sialic acid as a therapeutic modality in proteinuric renal disease.
